Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | PPARG | P37231 | 5/20 | 0.73 |
| ▸ | F7 | P08709 | 4/20 | 0.73 |
| ▸ | F3 | P13726 | 4/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.73 |
| ▸ | PPARD | Q03181 | 4/20 | 0.73 |
| ▸ | PPARA | Q07869 | 4/20 | 0.73 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.73 |
| ▸ | FABP3 | P05413 | 3/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.73 |
| ▸ | FABP4 | P15090 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.73 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18325614 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL15908483 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL15908480 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL15908489 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL15908476 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL11893268 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL9183242 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL3414485 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL21302754 | 1.00 | ALDH1A1 (0.73) | ALDH1A1PPARGF7F3KDM4E | |
| SCHEMBL10740192 | 0.98 | PPARG (0.72) | ALDH1A1PPARGF7F3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024019953-A1 | METHOD OF ENHANCING RECOVERY FROM LONG COVID | Synaptogenix, Inc. (US) | 2024-01-25 | — | — | WO | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230295617-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | WAVE LIFE SCIENCES LTD. (SG) | 2023-09-21 | — | — | US | disclosed |
| US-20230295617-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | WAVE LIFE SCIENCES LTD. (SG) | 2023-09-21 | — | — | US | disclosed |
| US-20230265429-A1 | SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE THEREOF | Arrowhead Pharmaceuticals, Inc. | 2023-08-24 | — | — | US | disclosed |
| US-20230232884-A1 | NUTRITIONAL FORMULA | BUILDING BLOCK NUTRITIONALS, LLC (US) | 2023-07-27 | — | — | US | disclosed |
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-20220401467-A1 | OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2022-12-22 | — | — | US | disclosed |
| EP-1909918-B1 | SKIN LIGHTENING COMPOSITIONS | AROMTECH LTD (FI) | 2013-09-04 | — | — | EP | disclosed |
| US-8455421-B2 | Compositions and methods for the removal of chewing gum residues from substrates | EXPELLIERE INT LTD (GB) | 2013-06-04 | — | — | US | disclosed |
| US-20120136049-A1 | ANTIBACTERIAL AGENT | OSAKA UNIVERSITY (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20120095075-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| US-20120027796-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20110319309-A1 | COMPOSITIONS AND METHODS FOR THE REMOVAL OF CHEWING GUM RESIDUES FROM SUBSTRATES | ENVIROWAYS TECHNOLOGIES LIMITED (GB) | 2011-12-29 | — | — | US | disclosed |
| US-20110046599-A1 | Multi-Day Delivery Of Biologically Active Substances | SAMOS PHARMACEUTICALS LLC | 2011-02-24 | — | — | US | disclosed |
| US-20110046599-A1 | Multi-Day Delivery Of Biologically Active Substances | SAMOS PHARMACEUTICALS LLC | 2011-02-24 | — | — | US | disclosed |
| US-20110003889-A1 | MEMBRANE FUSION INHIBITOR | KAIHATSU, Kunihiro (JP) | 2011-01-06 | — | — | US | disclosed |
| US-20090005508-A1 | EPOXIDIZED ESTERS OF VEGETABLE OIL FATTY ACIDS AS REACTIVE DILUENTS | ARCHER-DANIELS-MIDLAND COMPANY | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | MGLL, UGCG, DAGLA | ALDH1A1 2005/4885PPARG 347/4885F7 2573/4885 |
| US-20110046599-A1 | Multi-Day Delivery Of Biologically Active Substances | GUSB, SERPINA6, CD44 | ALDH1A1 957/4885PPARG 2727/4885F7 1549/4885 |
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | CPT1B, MUSK, MYLK2 | ALDH1A1 1330/4885PPARG 271/4885F7 4629/4885 |
| US-20230232884-A1 | NUTRITIONAL FORMULA | FABP2, ALOX5, LPO | ALDH1A1 3812/4885PPARG 467/4885F7 532/4885 |
| US-20230295617-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | ELOVL6, ELOVL5, ELOVL1 | ALDH1A1 2846/4885PPARG 86/4885F7 3470/4885 |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | ALDH1A1 2005/4885PPARG 347/4885F7 2573/4885 |
| US-20220401467-A1 | OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF | TLR9, RNGTT, NT5C3B | ALDH1A1 4085/4885PPARG 2903/4885F7 3960/4885 |
| US-20120136049-A1 | ANTIBACTERIAL AGENT | TEAD4, ELOVL6, TEAD1 | ALDH1A1 677/4885PPARG 18/4885F7 3497/4885 |
| US-20230265429-A1 | SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE THEREOF | MUSK, MYLK2, TNNC1 | ALDH1A1 2528/4885PPARG 498/4885F7 3177/4885 |
| US-20120095075-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | CETP, LCAT, NPC1L1 | ALDH1A1 3847/4885PPARG 1038/4885F7 2424/4885 |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | ALDH1A1 2005/4885PPARG 347/4885F7 2573/4885 |
| US-20120027796-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | CETP, ABCB4, LCAT | ALDH1A1 4201/4885PPARG 1391/4885F7 1406/4885 |
| US-20110003889-A1 | MEMBRANE FUSION INHIBITOR | FLOT1, NSF, VAMP7 | ALDH1A1 2332/4885PPARG 370/4885F7 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.